Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 13 min ago
PreprintAll rights reservedbioRxiv

TFE3 fusions drive expression of CD44 and SPP1 in Translocation Renal Cell Carcinoma

17 more authors
  1. 1Johns Hopkins University School of Medicine

Related

  1. Differentiating Xp11.2/TFE3 translocation renal cell carcinoma from clear cell carcinoma: performance of a radiomics model.
    Yi Liu, Kexin Wang, Yaofeng Zhang +5
    BMC cancerPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMCDOAJ
  2. Comparative Immunohistochemical Analysis of FAP and c-MET Expression Across Renal Cell Carcinoma Subtypes: Preliminary Results and Potential Theranostic Implications.
    Lena M Unterrainer, Adrien Holzgreve, Sophie C Siegmund +6
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Endothelial p16 expression identifies a subgroup of clear cell renal cell carcinoma with favorable prognosis
    Michael Stoffel, Katharina Baschun, Melina Kehl +8
    BMC CancerPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  4. Exploratory clinical-CT machine learning characterization of CK7 expression in clear cell renal cell carcinoma
    Qiansen Lin, Gengyun Miao, Xi Jia +5
    BMC CancerPeer-reviewedCC BYFull textMedical imaging & radiologyDOAJ
  5. Editor’s Note: ‘Expression of Concern: MGST2hi PMNs mediate NETs and drive pericyte-to-myofibroblast transition in RA-ILD’
    American journal of respiratory cell and molecular biologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
BibTeX
@misc{asrani2026tfe3,
  title = {{TFE3 fusions drive expression of CD44 and SPP1 in Translocation Renal Cell Carcinoma}},
  author = {K. Asrani and J. Woo and T. Vidotto and K. Feng and A. Lorenzetti and E. Imada and H. Li and R. Singh and A. Thotakura and S. Ray and L. Oliveira and A. Amaral and V. Palande and R. Anchoori and J. Mandal and R. Elias and C. Thoburn and M. M. Rana and H. N. Gangule and A. Gao and P. Phatak and J. Donahue and Y. Ged and N. Singla and J. Copland and L. Schmidt and W. M. Linehan and P. Argani and T. Lotan},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.18.752493},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.18.752493v1},
}
RIS
TY  - UNPB
TI  - TFE3 fusions drive expression of CD44 and SPP1 in Translocation Renal Cell Carcinoma
AU  - K. Asrani
AU  - J. Woo
AU  - T. Vidotto
AU  - K. Feng
AU  - A. Lorenzetti
AU  - E. Imada
AU  - H. Li
AU  - R. Singh
AU  - A. Thotakura
AU  - S. Ray
AU  - L. Oliveira
AU  - A. Amaral
AU  - V. Palande
AU  - R. Anchoori
AU  - J. Mandal
AU  - R. Elias
AU  - C. Thoburn
AU  - M. M. Rana
AU  - H. N. Gangule
AU  - A. Gao
AU  - P. Phatak
AU  - J. Donahue
AU  - Y. Ged
AU  - N. Singla
AU  - J. Copland
AU  - L. Schmidt
AU  - W. M. Linehan
AU  - P. Argani
AU  - T. Lotan
PY  - 2026
DA  - 2026/09/18
PB  - bioRxiv
DO  - 10.64898/2026.09.18.752493
UR  - https://www.biorxiv.org/content/10.64898/2026.09.18.752493v1
ER  -